Category Archives: Sector Specific

Transplantation of organs and human tissues

The donation and transplantation of human organs, tissues and cells is a complex domain that touches on questions of health, law and ethics. These questions are intrinsically connected. Thus, it demands a stringent regulation by public authorities so as to prevent serious health risks and eventual abuses of the consent given by the donor. Furthermore, the increased demand for organs combined with the globalisation has prompted the phenomena of organ trafficking and “transplant tourism”. These phenomena require additional regulation, ideally at global level. Continue reading Transplantation of organs and human tissues

Who is a refugee? Regulatory approaches.

When regulating the domain of asylum, it is advisable to build on existing international criteria or to make use of specific regional instruments. We examine these in the first part of this article (I.) Furthermore, we present here some national regulations with different degrees of complexity that can serve as reference (II.). Moreover, we highlight some particular provisions that might be of interest to regulators (III.). Finally, we analyse in more detail the proposal of the European Commission for a “Qualification Regulation” (IV.). Continue reading Who is a refugee? Regulatory approaches.

Reference legislation on medicines

Regulators who wish to develop or amend regulation for their respective jurisdiction might wish not to start from scratch, but to learn from other jurisdictions. Therefore we present here some legislation on medicines / pharmaceuticals / drugs of different jurisdictions as models. The models have different degrees of complexity. We start with rather simple models and go up to the quite complex models. Continue reading Reference legislation on medicines

Decentralized 3D-printing: a regulatory challenge

Summary

3D-printing of products in decentralized manufacturing constitutes a regulatory challenge. Normal product legislation will mostly not cover it. Thus there is a regulatory gap. Subject to the risks of the products and their manufacturing, it is worthwhile closing this gap.

If need there is, the gap can be closed by creating specific obligations for the designers of the product, for the owners of print-shops, the manufacturers of 3D-printers and sometimes even for the clients. The regulatory approach presented here can be adapted to atypical cases. It can also be used to cope with:

– devices sold as kits, and

– the marketing of manufacturing instructions for dangerous devices.

Continue reading Decentralized 3D-printing: a regulatory challenge